Rosuvastatin Slows Progression of Carotid Intima-Media Thickness: The METEOR-China Randomized Controlled Study.
Journal Information
Full Title: Stroke
Abbreviation: Stroke
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Vascular Diseases
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Disclosures Michiel L. Bots declares no conflicts of interest, apart from being paid for his services by the organization that received the METEOR-China grant from AstraZeneca to run the study. The payment went to UMC Utrecht. Drs Karlson, Zhao, Wei, and Meng are employees of AstraZeneca. The other authors report no conflicts."
"Sources of Funding The METEOR-China study was funded by AstraZeneca. AstraZeneca was involved in study design, conduct, and data management and analysis. AstraZeneca was given an opportunity to review the article for scientific accuracy."
"Registration:: URL: https://www.clinicaltrials.gov; Unique identifier: NCT02546323."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025